Full Professor, Institut de recherches cliniques de Montréal

Dr. André Veillette is Full Research Professor at the IRCM and Université de Montréal. Throughout his career, he has worked in the field of immunology where he helped found the field of immune cell activation 30 years ago. Since then, he has made important discoveries regarding CD4 and CD8 T cell co-receptors and surface antigens, the protein tyrosine kinases Csk and Lck, the role of the adaptor molecule SAP in immune regulation and the role of innate immune cells in immuno-oncology. These and other discoveries have provided fundamental insights into the immunological mechanisms of health and ...

Dr. Cécile Tremblay, is medical microbiologist and infectious diseases specialist at Centre Hospitalier de l’Université de Montreal. She is the Director of the Pfizer/Université de Montreal Chair on HIV translational research. She set up two pan-canadian cohorts to study the determinants of disease progression including premature aging phenotypes associated with HIV. Her research program also includes studying genetic viral evolution and its impact on viral entry and drug resistance as well as Pre-exposure Prophylaxis. She has recently developed several research projects related to COVID-19. ...

Professor, University of Alberta

Dr. Rachubinski's research has led to a molecular mechanistic understanding of peroxisomeassembly and of how assembly goes awry in the peroxisome biogenesis disorders (PBDs). Elucidation of the genes and pathways involved in peroxisome biogenesis and knowledgeof the dysfunctionality in these systems that results in the clinical manifestations of the PBDshave provided an initial therapeutic treatment for these diseases. At the University ofAlberta, he has built a world-class department focused on mechanistic cell biology and has recruited exceptional investigators working to link cell ...

Dean, USC School of Pharmacy, University of Southern California

Dr. Papadopoulos is the Director of The Research Institute of the McGill University Health Centre (MUHC) and Professor in the Faculty of Medicine at McGill University. He holds a Canada Research Chair in Biochemical Pharmacology and the Phil Gold Chair in Medicine at McGill/MUHC. Dr. Papadopoulos’ research focuses on the pathophysiology and treatment of diseases related to altered steroid hormone synthesis. His work has led to a better understanding of the pathways leading to steroid hormone synthesis, the pharmacology of steroid formation in the periphery and brain, and the identification of ...

Arline & Pete Harman Prof. for The Chair Dept. Pediatrics, Stanford University

Hugh O'Brodovich MD, FRCP(C) attended the University of Manitoba where he received his medical degree and training in pediatrics and pulmonary diseases. After further research and clinical training at Columbia University he assumed his first faculty position in 1981 at McMaster University. In 1986 he moved to the University of Toronto/Hospital for Sick Children and held the positions of Chair of Pediatrics/Paediatrician-in-Chief from 1996-2006. During that time he participated in major initiatives to improve the coordination, integration and delivery of health care to children in Ontario, ...

President, University of Michigan

Santa Ono serves as the 15th President of UBC. He was the 28th President of the University of Cincinnati. Educated the University of Chicago, McGill and Harvard, Ono served on the faculties of Johns Hopkins, Harvard, UCL and Emory Universities. He has served on the editorial boards of Journal of Immunology and Journal of Biological Chemistry. He has been elected a Fellow of the American Association for the Advancement of Sciences (FAAAS), the Royal Society of Chemistry (MRSC) and the Canadian Academy of Health Science. In 2017 he was awarded the Alumni Achievement Award from the University of ...

Professor of Medicine and Physiology; Director, Centre for t, University of Manitoba

Arnold Naimark is currently Professor of Medicine and Physiology at the University of Manitoba, the Director of the Centre for the Advancement of Medicine and the founding Chair of the Canadian Health Services Research Foundation. He had a distinguished career as a Professor of Medicine at the University of Manitoba before becoming Dean of the Faculty of Medicine from 1971 to 1981, after which he served as the University’s President and Vice- Chancellor from 1981 to 1996. Dr. Naimark has served and continues to serve on many committees, boards and advisory bodies in such positions as Chair, ...

Director, Centre of Genomics & Policy, Faculty of Medicine, McGill University

Bartha Maria Knoppers, PhD, holds the Canada Research Chair in Law and Medicine and the Chaire d’excellence Pierre Fermat (France). She is Professor at the Faculté de droit, Université de Montréal and Senior Researcher at the Centre de recherche en droit public (CRDP). She is a graduate of McMaster University (B.A.), University of Alberta (M.A.), McGill University (LL.B., B.C.L.), Cambridge University, U.K., (D.L.S.), Sorbonne Paris I) (Phd.) and was admitted to the Bar of Québec in 1985. She has authored numerous articles and books. Professor Knoppers is former Chair of the International ...

Professor, University of Calgary

Benedikt Hallgrímsson is an international leader in the study of birth defects and the developmental genetics of anatomical variation. He was awarded the Rohlf Medal for orphometrics in 2015 and elected AAAS Fellow in 2019 for integrating imaging and morphometrics with developmental biology. Funded by CIHR, NSERC and NIH, his 160 publications have over 9000 citations. Hallgrimsson has held leadership roles at the University of Calgary where he led creation of the Bachelor of Health Sciences and co-led the successful proposal to create a Faculty of Veterinary Medicine. He is currently ...

VP & Professor, University of Toronto

Professor Leah Cowen has pioneered genome-scale analyses of deadly fungal pathogens to understand how they cause disease and evolve resistance to the limited arsenal of drugs available to kill them. Her interdisciplinary approaches to understand host-pathogen interactions and identify new antifungals and their targets have catalyzed the discovery of novel strategies to treat fungal infectious disease. Cowen is developing life-saving medicines as co-Founder and Chief Scientific Officer of Bright Angel Therapeutics and is transforming global scientific communities by leading both the CIFAR ...